会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • 1-Phenyl-2-aminocarbonylindole compounds, preparation thereof and
pharmaceutical compositions containing them
    • 1-苯基-2-氨基羰基吲哚化合物,其制备方法和含有它们的药物组合物
    • US4803198A
    • 1989-02-07
    • US885684
    • 1986-07-15
    • Heinrich-Wilhelm OhlendorfWilhelm KaupmannUlrich KuehlGerd BuschmannStephen J. Magda
    • Heinrich-Wilhelm OhlendorfWilhelm KaupmannUlrich KuehlGerd BuschmannStephen J. Magda
    • C07D209/14A61K31/40A61K31/403A61K31/404A61P9/06C07D209/24C07D209/42A61K31/55C07D403/12C07D403/14
    • C07D209/42
    • New 1-phenyl-2-aminocarbonylindole compounds are described which have the general formula I ##STR1## where R.sub.1 is a hydrogen atom, or a lower alkyl, alkenyl, cycloalkylalkyl radical, R.sub.2 is a hydrogen atom or a lower alkyl radical, R.sub.3 is a hydrogen or halogen atom, or a lower alkyl, hydroxyl or lower alkoxy radical, R.sub.4 is a hydrogen or halogen atom, or a lower alkyl, hydroxyl or lower alkoxy radical, or, if R.sub.3 is a hydrogen atom, R.sub.4 may be a nitro or trifluoromethyl radical, or R.sub.3 and R.sub.4 together denote a methylenedioxy or ethylenedioxy radical, R.sub.5 has the meanings given for R.sub.3, R.sub.6 has the meanings given for R.sub.4, R.sub.7 is a hydrogen atom or, if R.sub.5 and R.sub.6 are lower alkoxy radicals, R.sub.7 may also be a lower alkoxy radical, R.sub.8 and R.sub.9 are each a hydrogen atom or a lower alkyl radical or, together with the nitrogen atom, form a heterocyclic group, and Z is an alkylene chain which is optionally substituted by hydroxyl. The compounds have pharmaceutical properties, in particular antiarrhythmic properties. The compounds may be in the form of the free bases or acid addition salts. Pharmaceutical compositions containing these compounds are described as is a method of preparing them.Valuable intermediates for the production of these compounds and methods of preparing the intermediates are also described.
    • 描述了具有通式Ⅰ的新的1-苯基-2-氨基羰基吲哚化合物,其中R 1是氢原子,或低级烷基,烯基,环烷基烷基,R 2是氢原子或低级烷基,R 3 是氢或卤素原子,或低级烷基,羟基或低级烷氧基,R4是氢或卤素原子,或低级烷基,羟基或低级烷氧基,或者如果R3是氢原子,R4可以是 硝基或三氟甲基,或R 3和R 4一起表示亚甲二氧基或亚乙二氧基,R 5具有R 3的含义,R 6具有对R 4的定义,R 7是氢原子,或者如果R 5和R 6是低级烷氧基,则R 7 也可以是低级烷氧基,R 8和R 9各自为氢原子或低级烷基,或者与氮原子一起形成杂环基,Z为任选被羟基取代的亚烷基链。 这些化合物具有药物性质,特别是抗心律失常性质。 化合物可以是游离碱或酸加成盐的形式。 含有这些化合物的药物组合物被描述为制备它们的方法。 还描述了制备这些化合物的有价值的中间体和制备中间体的方法。
    • 6. 发明授权
    • 3,7-Diazabicyclo(3,3,1)nonane compounds and their use in treating heart
disease
    • 3,7-二氮杂双环(3,3,1)壬烷化合物及其在治疗心脏病中的应用
    • US4550112A
    • 1985-10-29
    • US532762
    • 1983-09-16
    • Uwe SchoenBernd HachmeisterWolfgang KehrbachUlrich KuehlGerd Buschmann
    • Uwe SchoenBernd HachmeisterWolfgang KehrbachUlrich KuehlGerd Buschmann
    • A61K31/435A61P9/06A61P9/10C07D471/08C07D471/10A61K31/445
    • C07D471/08C07D471/10
    • Novel 3,7-diaza bicyclo-(3,3,1)-nonane compounds are described which are represented by the formula: ##STR1## wherein Z.sub.1 and Z.sub.2 each denotes hydrogen,R.sub.1 and R.sub.2 each denotes (A) a substituent which contains up to 12 carbon atoms and which is selected from the group consisting of alkyl, alkenyl, and alkinyl, or (B) a cycloalkyl group containing 3 to 6 carbon atoms which is attached to the nitrogen atom directly or by an alkylene group containing 1 to 3 carbon atoms, andR.sub.3 and R.sub.4 each denotes an alkyl group with up to 7 carbon atoms, or both together form an alkylene chain represented by the formula --(CH.sub.2).sub.n --, wherein n is an integer ranging between about 3 and 6, such that the substituents R.sub.1, R.sub.2, R.sub.3, and R.sub.4 together contain at least 5 carbon atoms. Also described are processes of producing said compounds, pharmaceutical compositions containing compounds of Formula I, and methods of preparing and using said compositions.
    • 描述了由下式表示的新颖的3,7-二氮杂双环(3,3,1) - 壬烷化合物:其中Z1和Z2各自表示氢,R1和R2各自表示(A)含有 至多12个碳原子,并且其选自烷基,烯基和炔基,或(B)含有3至6个碳原子的环烷基,其直接连接到氮原子上或通过含有1至 3个碳原子,并且R 3和R 4各自表示具有至多7个碳原子的烷基,或两者一起形成由式 - (CH 2)n - 表示的亚烷基链,其中n为约3至6的整数, 使得取代基R 1,R 2,R 3和R 4一起含有至少5个碳原子。 还描述了生产所述化合物的方法,含有式I化合物的药物组合物,以及制备和使用所述组合物的方法。
    • 10. 发明申请
    • CAMERA UNIT FOR A MOTOR VEHICLE
    • 电动车辆摄像机单元
    • US20130235204A1
    • 2013-09-12
    • US13822476
    • 2011-08-24
    • Gerd Buschmann
    • Gerd Buschmann
    • H04N7/18
    • H04N7/18B60R11/04B60R2011/0094
    • Camera unit (3, 3′) having a protective element (4, 4′) for recording images of an external region for a motor vehicle (1), which camera unit is connected to a display apparatus, which is arranged within the motor vehicle (1), via a controller, wherein the camera unit (3, 3′) is arranged within a recess (5, 5′), which is provided in the motor vehicle (1), such that it is covered by means of the protective element (4, 4′) in an inactive operating position, and the camera unit (3, 3′) and/or the protective element (4, 4′) can be moved into an enable position, which serves as the active operating position for recording images of the external region, by a drive element after activation of a first operating element, in particular by the activation of the reverse gear, which is in the form of the first operating element, of the motor vehicle (1), and at least a second operating element (6, 6′) is provided, wherein the camera unit (3, 3′) and/or the protective element (4, 4′) can be moved into the enable position which is suitable for recording images of the external region by the drive element after activation of the second operating element (6, 6′), wherein the second operating element (6, 6′) can be operated by the user only outside the motor vehicle (1).
    • 具有用于记录机动车辆(1)的外部区域的图像的保护元件(4,4')的相机单元(3,3'),该相机单元连接到布置在机动车辆内的显示装置 (1),经由控制器,其中所述相机单元(3,3')布置在设置在所述机动车辆(1)中的凹部(5,5')内,使得其被所述 处于非活动操作位置的保护元件(4,4'),并且相机单元(3,3')和/或保护元件(4,4')可以移动到使能位置,该位置用作主动操作 通过驱动元件在第一操作元件启动之后,特别是通过启动机动车辆(1)的第一操作元件形式的倒档时,记录外部区域的图像的位置, 并且提供至少一个第二操作元件(6,6'),其中相机单元(3,3')和/或保护元件(4,4')可以被移动 o在第二操作元件(6,6')启动之后适合于通过驱动元件记录外部区域的图像的使能位置,其中第二操作元件(6,6')可以由用户操作 在机动车辆(1)外。